中医药

Search documents
汇聚北京优势资源 助力南阳高质量发展
Bei Jing Ri Bao Ke Hu Duan· 2025-05-14 21:44
北京市委外办市政府外办有关负责人表示,南阳是南水北调中线工程核心水源地和渠首所在地。饮水思源, 市委外办市政府外办将深入落实市委市政府关于南水北调对口协作决策部署,用好外事资源渠道,搭建协作 新平台,发挥行业协会商会专业、信息、人才、机制等独特优势,积极推动与南阳市建立常态化沟通机制, 在产业链上下游开展精准对接,助力先进的产业发展模式、管理经验和创新技术落地,激活城市发展新动 能,推动"全国性行业协会商会进南阳"成为京宛协作新亮点。 全国性行业协会商会负责人在世界月季大观园参观考察。 本报记者 蔡代征摄 活动期间,相关行业协会商会还分领域分区域分专题前往邓州、淅川、内乡等县市,进企业、进市场、进产 业园区、进专业部门,就中医药、服装设计、开发区建设、汽车零部件产业发展等方面开展考察对接。 本报讯(记者 宋佳音)同饮一渠水、京宛一家亲。近日,"全国性行业协会商会进南阳"活动在河南南阳举 行。此次活动由北京市委外办市政府外办和南阳市委市政府共同举办。中国水利企业协会、中国风景名胜区 协会等15家全国性行业协会商会受邀走进南阳考察,汇聚北京优势资源,发挥行业特色优势,对接当地转型 需求,助力南阳高质量发展。 走进 ...
浙农股份(002758) - 2024年度业绩说明会投资者活动记录表
2025-05-13 12:07
Group 1: Smart Agriculture and Rural Revitalization - The company focuses on smart agriculture as part of its digital strategy, exemplified by the "Zhe Nong Yun" grain and oil future farm project, managing 10,000 acres of rice through a digital management platform [1] - The project has been recognized as an excellent case in national smart agriculture construction and reported by major media outlets during the 2024 spring plowing season [1] - The company has received awards for its contributions to rural revitalization, including the "Outstanding Practice Case" in the 2023 Best Practices for Rural Revitalization [2] Group 2: Agricultural Input Market and Competitive Landscape - The agricultural input market in China is characterized by a fragmented structure, with the supply and marketing cooperative system holding a dominant position [2] - The company benefits from macro policy advantages, talent mechanisms, industry leadership, resource branding, and channel network advantages in the agricultural input sector [2] - The company aims to increase market share by leveraging its competitive advantages as the agricultural input industry transitions to a more integrated service model [2] Group 3: Financial Performance and Stock Buyback - As of April 2025, the company has repurchased approximately 11.89 million shares, accounting for 2.28% of total share capital, with a total transaction amount of around 100 million yuan [4] - The company has implemented a stock buyback plan to enhance investor confidence and stabilize stock prices, with a total dividend payout exceeding 600 million yuan over the past four years [7] Group 4: New Energy Vehicle Business - In 2024, the company sold over 6,000 new energy vehicles, representing a 19% year-on-year increase and accounting for 17% of total vehicle sales [4] - The company is exploring partnerships with strong, low-risk new energy brands to expand its market presence [4] Group 5: Agricultural Social Services and Future Farms - The company has established 19 agricultural service centers in Zhejiang Province and conducted over 3,800 farmer meetings and technical promotion sessions in 2024 [5] - The "Future Farm" projects focus on the entire grain and oil industry chain, with land transfer planting areas reaching 30,000 acres [5] Group 6: Market Management and Investor Relations - The company emphasizes market management and aims to enhance its market value through quality development and investor returns, including cash dividends [7] - The company plans to optimize employee entrepreneurship mechanisms and deepen stock incentive plans to improve investor relations [7]
母亲节 同仁堂加味逍遥丸助力女性健康
Zhong Guo Zhi Liang Xin Wen Wang· 2025-05-13 09:13
Group 1 - The "She Health - Meituan Women's Health Public Welfare Program" was officially launched in Shanghai, focusing on creating a health management system for over 30 working women through a collaboration between government, enterprises, and medical institutions [1][3] - Beijing Tongrentang, a representative brand of traditional Chinese medicine, emphasizes the importance of liver health for women and integrates the concept of "preventive treatment" into health management, addressing modern women's health needs [3][5] - The program aims to enhance health awareness from individual to societal levels, promoting the core idea of "soothing the liver and relieving stress" [3][5] Group 2 - The collaboration with Meituan to release the "Women's Health White Paper" is a significant initiative in response to the "Healthy China" strategy, aiming to provide more precise health services through data insights and resource integration [5] - The event featured a health consultation area where experienced traditional Chinese medicine practitioners offered personalized health solutions for issues like "liver stagnation and qi deficiency" [7] - Beijing Tongrentang's mission is to make traditional Chinese medicine accessible to everyone, ensuring that every working woman can thrive with a balanced approach to health [7]
国医大师石学敏院士逝世,生前发明丹芪偏瘫胶囊
Sou Hu Wang· 2025-05-13 06:08
Core Viewpoint - The passing of Shi Xue Min, a prominent figure in modern acupuncture and traditional Chinese medicine, marks a significant loss for the medical community in China and globally [1][3][4] Group 1: Contributions to Medicine - Shi Xue Min was a pioneer in acupuncture, known for his innovative "Stroke Unit" therapy, which includes treatments like acupuncture and Danqi Paralysis Capsules for stroke patients [1][3] - He developed a comprehensive treatment plan for stroke that integrates acupuncture, rehabilitation training, diet, psychology, and health education, recognized as one of the top ten projects for promotion by the National Administration of Traditional Chinese Medicine [3][4] Group 2: Academic and Research Achievements - Shi Xue Min led over 43 research projects, including the National 973 Program, and received numerous awards, including one National Science and Technology Progress Award and 33 provincial and ministerial-level awards [4] - He published over 100 papers and authored more than 50 books, contributing significantly to the academic field of traditional Chinese medicine [4] Group 3: Education and Mentorship - Shi Xue Min trained nearly 500 domestic and over 80 international doctoral and master's students, significantly impacting the education of future practitioners in traditional Chinese medicine [3][4] - His unique acupuncture training classes have seen participation from over 80,000 doctors, promoting standardized practices in acupuncture [3]
国潮精品闪耀西部跨境盛会 政企同心共促川货扬帆出海
Sou Hu Cai Jing· 2025-05-12 20:27
在万物并秀的五月,第四届西部跨境电商博览会于成都世纪城新国际会展中心盛大启幕,这场汇聚全球 商业智慧与资源的行业盛会,吸引了来自世界各地的目光。在这场充满机遇与挑战的舞台上,四川省清 沁诗语生物科技有限公司携旗下明星产品藏金倩角璀璨亮相,不仅展现了川企的创新实力与文化自信, 更成为本届博览会中令人瞩目的焦点。 走进博览会现场,热闹非凡的氛围扑面而来,各个展位争奇斗艳,展示着前沿的产品和先进的技术。而 在泸州馆内,四川省清沁诗语生物科技有限公司的展位以独特的设计和亮眼的产品脱颖而出,瞬间吸引 了众多参展商和参观者的驻足。 藏金倩角作为入围《了不起的国货》的国潮好物代表,承载着深厚的文化底蕴与卓越的品质。该产品依 托传统中医药智慧,精选多种珍贵天然草本植物,经过现代先进工艺精心研制而成。其不仅在产品功效 上表现出色,能够为消费者提供优质的健康护理解决方案,更在文化内涵上独树一帜,将中国传统中医 药文化与现代生活需求完美结合,展现出独特的国潮魅力。自上市以来,藏金倩角凭借其出色的品质和 良好的口碑,在市场上赢得了广泛认可,成为消费者信赖的国货精品。此次亮相西部跨境电商博览会, 更是藏金倩角迈向国际市场的重要一步,彰 ...
医药行业周报:关注血透、药房等细分领域投资机遇
Minsheng Securities· 2025-05-12 10:23
医药行业周报 关注血透、药房等细分领域投资机遇 2025 年 05 月 12 日 ➢ 医药周观点:医药设备招投标持续复苏,重点关注血透、超声等细分领域国产替 代机遇。此外,连锁药房领域内随着中小厂商的陆续出清,龙头厂商有望借助行业加 速整合机遇迎来市占率提升。 ➢ 1)创新药:云顶新耀布地奈德肠溶胶囊获得 NMPA 完全批准,翰森制药阿美 替尼辅助适应症获批上市,建议关注国内外研发进展。2)CXO:国内需求逐步回暖, 海外需求平稳向上,且目前对关税政策免疫,看好板块龙头企业逐季度订单和报表的 持续兑现带来的估值修复,重点关注药明生物、药明康德、凯莱英和康龙化成。3) 中医药:中医药方面,后续建议关注与生育补贴息息相关的标的,例如具备儿科用药 布局的济川药业、葵花药业等。4)疫苗及血制品:持续看好静丙行业未来 3-5 年的 发展潜力,其次关注浆站数量变化及头部集中背景下吨浆利润提升驱动的行业上行周 期中潜在受益的龙头公司,重视重组人白的获批进程以及潜在的产业变革。疫苗方向 基本面整体承压但部分重点公司业绩边际改善,关注重点公司 24 年下游库存周期改 善带来的业绩拐点及 mcv4 疫苗 25 年市场拓展情况。5 ...
医药行业周报:关注血透、药房等细分领域投资机遇-20250512
Minsheng Securities· 2025-05-12 09:51
医药行业周报 关注血透、药房等细分领域投资机遇 2025 年 05 月 12 日 ➢ 医药周观点:医药设备招投标持续复苏,重点关注血透、超声等细分领域国产替 代机遇。此外,连锁药房领域内随着中小厂商的陆续出清,龙头厂商有望借助行业加 速整合机遇迎来市占率提升。 ➢ 1)创新药:云顶新耀布地奈德肠溶胶囊获得 NMPA 完全批准,翰森制药阿美 替尼辅助适应症获批上市,建议关注国内外研发进展。2)CXO:国内需求逐步回暖, 海外需求平稳向上,且目前对关税政策免疫,看好板块龙头企业逐季度订单和报表的 持续兑现带来的估值修复,重点关注药明生物、药明康德、凯莱英和康龙化成。3) 中医药:中医药方面,后续建议关注与生育补贴息息相关的标的,例如具备儿科用药 布局的济川药业、葵花药业等。4)疫苗及血制品:持续看好静丙行业未来 3-5 年的 发展潜力,其次关注浆站数量变化及头部集中背景下吨浆利润提升驱动的行业上行周 期中潜在受益的龙头公司,重视重组人白的获批进程以及潜在的产业变革。疫苗方向 基本面整体承压但部分重点公司业绩边际改善,关注重点公司 24 年下游库存周期改 善带来的业绩拐点及 mcv4 疫苗 25 年市场拓展情况。5 ...
以岭健康亮相莫干山大会:在传承创新中提升品牌力量,让中医药融入人民生活
Sou Hu Wang· 2025-05-12 03:59
Group 1: Conference Overview - The 2025 World Brand Moganshan Conference was held in Deqing, Zhejiang, focusing on the theme of "openness, cooperation, and win-win" to promote Chinese brands globally [1] - The conference highlighted the importance of traditional Chinese medicine (TCM) as a key to unlocking Chinese civilization and emphasized the supportive policies for the TCM industry since the 18th National Congress of the Communist Party [1] Group 2: Company Profile - Yiling Health, a subsidiary of Yiling Pharmaceutical, is dedicated to the health industry and embodies the cultural heritage of TCM while driving innovation [2] - The company has established a comprehensive health management system that integrates medicine, health, and wellness, emphasizing the shift from treatment to prevention [2] Group 3: Product Development - Yiling Health has developed a series of products based on the "Eight Principles of TCM Health Preservation," which include "Tongluo," "Yangjing," "Dongxing," and "Jingshen" [3][4][5] - The company has launched various health products, such as the "Tongluo Six Immortals" series, which addresses chronic diseases and promotes overall wellness [3] Group 4: Innovative Beverage Products - Yiling Health's herbal beverages, such as "Yimeng" and "Jinliwang," have gained popularity, becoming the sponsored drinks at the Moganshan Conference [6][8] - These beverages utilize TCM ingredients to address health concerns like blood sugar and sleep quality, aligning with consumer trends towards natural foods [6][8] Group 5: Market Strategy and Expansion - The company is leveraging the global health consumption upgrade to create a cooperative ecosystem, collaborating with various industries to expand its market reach [9] - Yiling Health aims to enhance its brand presence through a comprehensive online and offline operational matrix, targeting over 100 billion online exposures and gaining over 500,000 new users by 2023-2024 [10]
破局人口老龄化 八子补肾领航抗衰老“中国方案”
Cai Jing Wang· 2025-05-11 13:01
本文转载自海报新闻 莫干山下,华章再启,中国向世界讲述品牌故事。 5月9日至11日,以"品牌,让世界更美好"为主旨,2025世界品牌莫干山大会在浙江省德清县举行。本届大会由新华社品牌工作办公室、中国国家品牌网等联合主办,是510中国品 牌日期间全球规模最大的品牌盛会之一,吸引全球超4000名政商学界领袖、行业标杆企业代表及权威机构参与。 在这一方为世界搭建共享机遇、共同发展、互利共赢的中国舞台上,中医药抗衰老最新科研成果--八子补肾天然抗衰老产品的精彩亮相,吸引了众多目光。其在创新研发上的重大 突破,体现出中医药走向世界、助力人类健康事业的重要价值。 2025年4月,法国索邦大学 Guido Kroemer、Carlos López-Otín 等人在国际顶尖学术期刊《Cell》上发表综述论文,在此前提出的衰老有十二大生物学标志物的基础上,新增了细胞 外基质变化和心理-社会隔离,将衰老标志物扩展为十四个。 从西方科学视角来看,十四大衰老标志物涵盖了从细胞分子层面到心理社会层面的诸多因素,每一个标志物都如同精密仪器中的一个齿轮,相互关联、相互影响。 而中医药在抗衰老领域也有着独到的智慧和实践。其中,在中医气络学说 ...
2025世界品牌莫干山大会:以岭健康展现中医药品牌创新力
Sou Hu Wang· 2025-05-11 00:56
Core Insights - The article emphasizes the growing global recognition of Traditional Chinese Medicine (TCM) and its integration into modern health needs, showcasing the potential of TCM as a strategic resource in the global health industry [1][8] - Yiling Health is leveraging TCM culture and innovative product development to meet contemporary health demands, particularly through its unique product offerings and operational strategies [7][8] Group 1: TCM Cultural Integration - Yiling Health is deeply rooted in TCM culture and aims to merge traditional wisdom with modern health requirements, as demonstrated at the 2025 World Brand Moganshan Conference [1] - The company promotes the TCM preventive health concept of "treating before illness" and emphasizes the holistic approach of TCM, which addresses modern health challenges [1][2] Group 2: Product Development and Innovation - Yiling Health has developed a diverse product matrix based on the "Tongluo Health Eight Principles," which combines TCM wisdom with modern life sciences, focusing on circulation, nutrition, exercise, and mental health [2][3] - The company has created over a hundred product concepts and formulations targeting 18 common health scenarios, showcasing its strong R&D capabilities [3] Group 3: Market Trends and Consumer Demand - The rise of herbal health and the concept of "food as medicine" are becoming mainstream, with products like Yiling Health's plant-based beverages gaining popularity among health-conscious consumers [4][6] - The company's flagship products, Yimeng and Jinliwang, have achieved significant sales milestones, with Yimeng surpassing 100 million in sales in its first year [6] Group 4: Operational Strategies - Yiling Health has established a comprehensive operational system that includes online and offline sales strategies, collaborating with major e-commerce platforms and leveraging social media for brand exposure [7] - The company has successfully integrated technology and innovation into its operations, resulting in over 10 billion online exposures and the acquisition of more than 500,000 new users in 2023-2024 [7] Group 5: Future Outlook - Yiling Health aims to continue exploring the depths of TCM culture while innovating its products and services, contributing to the promotion of Chinese brands and TCM culture on a global scale [8]